|
Stacey Marie Fernandes B.S.
Principal Research Technician
B.S. in Biology, Emmanuel College, 2003 Stacey joined the Brown lab in August of 2009 when her previous PI retired, and thought this would be a great time to transition into clinical research. Her primary role in the lab is to manage all clinical trial bankings as it pertains to the CLL Center. She is also the liaison between collaborators inside and outside the Institute. In her free time Stacey can be found in her hometown Taunton volunteering with St. Vincent de Paul, singing in her barbershop chorus NoteAble Blend, in her backyard tending to her garden, and spending time with her family and friends. |
|
Binu Kandathilparambil Sasi Ph.D.Instructor
MSc in Medical Biochemistry, Mahatma Gandhi University, Kerala, India. PhD in Molecular Biology, Indian Institute of Technology Madras, Chennai, India, 2014 Post-Doctoral Fellow, International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy, 2014-2018 Post-Doctoral Fellow, UT Health San Antonio, Texas, 2018-2021 Binu joined Brown Lab in September 2021. Prior to join the Brown Lab, he was extensively trained in both CLL and DLBCL biology in his previous postdoc training. In Brown’s Lab, he will be working to understand the mechanism of both resistance and toxicity to PI3K inhibitors in CLL cohorts. This would help to improve the treatment strategies to overcome either resistance or will help to reduce toxicities by these agents. In his free time he enjoys travelling in and around Boston, cooking and hanging out with friends. |
|
John-Hanson Machado B.S.Senior Research Technician &
Operations Coordinator B.S. in Chemistry (ACS Certified), The George Washington University, 2016 |
|
Kiyomi Mashima M.D., Ph.D.Postdoctoral Research Fellow
M.D. in Jikei Medical University, Tokyo in Japan, 2012 Ph.D. in Jichi Medical University, Tochigi in Japan, 2019 Joined in DFCI 2020- and joined in this lab during 2021. I'm working on both experimental and clinical analysis of CLL. |
|
Mariia Mikhaleva M.D.Fulbright Scholar Alumnus
Ph.D. student in Hematology, St. Petersburg, Russia (anticipated graduate date is December 2023) M.D. in Medical Academy, St. Petersburg, Russia, 2014 Mariia joined the Lab in September 2022 as Visiting Researcher to accumulate academic knowledge and expertise in CLL research. She focused on clinical sequencing, clonal evolution patterns, and second primary tumors in CLL. Mariia adores traveling around the globe, believing it makes people open-minded. She enjoys yoga and hiking. |
|
Aishath Shanaz Naeem Ph.D.Scientist
BSc (Hons) in Genetics, University of Liverpool, Liverpool, UK, 2008 PhD in Skin Biology, University College London, London, UK, 2014 Post-Doctoral Fellow, University College London, London, UK. 2015-2017 Aishath joined Brown Lab at Dana-Farber Cancer Institute in September 2018. Her project involves looking at the potency and selectivity of next generation non-covalent BTK inhibitors. This work will help determine whether these inhibitors can be used to treat CLL patients who have progressed on prior treatment with covalent BTK inhibitors. In her spare time Aishath loves experiencing different cultures, traveling and exploring local restaurants in Boston area! |
|
Roberta Santos Azevedo M.D., Ph.D.Research Fellow
|
|
Saurabh Yadav Ph.D.Instructor, Medical Oncology, Division of Hematologic Neoplasia
MSc in Biotechnology, Indian Institute of Technology Bombay, Mumbai, India. 2012 Ph.D., Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2018 Post-doctoral research fellow and scholar, Memorial Sloan Kettering Cancer Center, New York City, 2018-2021 Saurabh completed his Ph.D. in the Departments of Medical Genetics and Surgical Gastroenterology at the Sanjay Gandhi Postgraduate Institute of Medical Sciences in Lucknow, India, where he focused on the genetics of gallbladder cancer. Following his Ph.D., he worked as a postdoctoral research scholar at Memorial Sloan Kettering Cancer Center in New York. In the Jennifer R. Brown laboratory, Saurabh's research centers on elucidating the molecular mechanisms underlying treatment resistance and toxicity in CLL patients treated with PI3K inhibitors. His goal is to improve therapeutic strategies for individuals with CLL. Outside of the lab, Saurabh enjoys outdoor hiking in nature, reading poetry, and watching TV and movies. |